Glenmark Specialty S.a.

Glenmark Pharmaceuticals Limited

Ashok Katkurwar

Ulhas R Dhuppad

Chandrakant Dhatrak

Rajesh Ankam

Yashwant Gupta

Neelima Khairatkar-Joshi

Abhay Kulkarni

Vikram Mansingh Bhosale

Chad Oh

Sudeesh K Tantry

Patrick Keohane

Piyush Agarwal

Dinesh Pradeep Wale

Michael Crick

Raveendra Pai

Rakshit Trivedi

Jitendra Patil

Ramakant Chanagare

The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator and a dose indicator. The present invention also relates to a process for preparing such a pharmaceutical composition and its use in the treatment of respiratory disorders such as for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema in a subject in need thereof (e.g., a human).

Metered dose inhaler for ipratropium bromide solution

A nasal dispensing device and pharmaceutical composition includes a container; a dispenser head having at least a pump, a dispensing channel, and a dispensing orifice; a dip tube; and a pharmaceutical composition comprising mometasone, an ester thereof (e.g., mometasone furoate), or a salt thereof and olopatadine or its salt (e.g., olopatadine hydrochloride). The container can have a conically shaped internal bottom, angled downwardly toward a center, and a further angularly deepened well, centrally located, with the dip tube extending into the well. An optional cap is provided that includes a sealing sleeve communicating in a seal tight manner with a perimeter of a lateral wall of the dispenser head.

Dispensing device and pharmaceutical composition for the treatment of rhinitis

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.

Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine

Growing community of inventors

Maharashtra, India

Ashok Katkurwar